Regulation of biotechnology in the United States, Canada, and Latin America

For biotechnology products that require review, regulatory review should be designed to minimize regulatory burden while assuring protection of public health and welfare. [Pg.33]

Regulatory programs should be designed to accommodate the rapid advances in biotechnology. Performance-based standards are, therefore, generally preferred over design standards. [Pg.33]

In order to create opportunities for the application of innovative new biotechnology products, all regulation in environmental and health areas - whether or not they address biotechnology - should use performance standards rather than specifying rigid controls or specific designs for compliance. [Pg.33]

Big Chemical Encyclopedia